{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:20:39Z","timestamp":1759580439998,"version":"3.44.0"},"reference-count":106,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:p>Women with epilepsy face additional challenges when compared to their peers. Hormonal influences may increase seizure activity, alter endocrine function, and affect fertility. In this population, antiepileptic drugs (AEDs) reduce the efficacy of contraception methods and increase the risk of fetal malformations. Other pertinent issues to women with epilepsy include breastfeeding as well as bone mineral health. This article summarizes our current, collective knowledge of these issues and makes specific recommendations with respect to management.<\/jats:p>","DOI":"10.5863\/1551-6776-14.4.212","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T20:08:34Z","timestamp":1603829314000},"page":"212-220","source":"Crossref","is-referenced-by-count":3,"title":["Women and Epilepsy"],"prefix":"10.5863","volume":"14","author":[{"given":"Sunila E.","family":"O'Connor","sequence":"first","affiliation":[{"name":"Department of Neurology, Section of Child Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Zupanc","sequence":"additional","affiliation":[{"name":"Department of Neurology, Section of Child Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"6 Suppl 3","key":"2020102716045578000_i1551-6776-14-4-212-b1","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1212\/WNL.66.66_suppl_3.S37","article-title":"Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy","volume":"66","author":"Zupanc","year":"2006","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1528-1157.1980.tb04074.x","article-title":"Catamenial Epilepsy: a review","volume":"21","author":"Newmark","year":"1980","journal-title":"Epilepsia"},{"issue":"suppl 4","key":"2020102716045578000_i1551-6776-14-4-212-b3","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1111\/j.1528-1157.1992.tb06227.x","article-title":"Hormones and epilepsy through the lifetime","volume":"33","author":"Morrell","year":"1992","journal-title":"Epilepsia"},{"issue":"6 Suppl 1","key":"2020102716045578000_i1551-6776-14-4-212-b4","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/NRL.0b013e31815c613d","article-title":"Special situations in epilepsy: women and the elderly","volume":"13","author":"Forcadas","year":"2007","journal-title":"Neurologist"},{"issue":"suppl 2","key":"2020102716045578000_i1551-6776-14-4-212-b5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3949\/ccjm.71.Suppl_2.S11","article-title":"Hormones and seizures","volume":"71","author":"Foldvary-Schaefer","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1528-1157.1993.tb02097.x","article-title":"How common is catamenial epilepsy?","volume":"34","author":"Duncan","year":"1993","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ana.20214","article-title":"Frequency of catamenial seizure exacerbation in women with localization-related epilepsy","volume":"56","author":"Herzog","year":"2004","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1528-1157.1997.tb01197.x","article-title":"Three patterns of catamenial epilepsy","volume":"38","author":"Herzog","year":"1997","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b9","first-page":"207","article-title":"A putative receptor for neurosteroids on the GABA receptor complex: the pharmacological properties and therapeutic potential of epalons","volume":"9","author":"Gee","year":"1995","journal-title":"Crit Rev Neurobiol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"2020102716045578000_i1551-6776-14-4-212-b11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eplepsyres.2004.09.003","article-title":"Role of neurosteroids in catamenial epilepsy","volume":"62","author":"Reddy","year":"2004","journal-title":"Epilepsy Res"},{"key":"2020102716045578000_i1551-6776-14-4-212-b12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1528-1157.2001.33600.x","article-title":"Acetazolamide in women with catamenial epilepsy","volume":"42","author":"Lim","year":"2001","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/jnnp.47.12.1279","article-title":"Intermittent clobazam for catamenial epilepsy: tolerance avoided","volume":"47","author":"Feely","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"suppl 9","key":"2020102716045578000_i1551-6776-14-4-212-b14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2005.00323.x","article-title":"Best practice guidelines for the management of women with epilepsy","volume":"46","author":"Crawford","year":"2005","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1212\/WNL.52.9.1917-a","article-title":"Progesterone therapy in women with epilepsy: a 3-year follow-up","volume":"52","author":"Herzog","year":"1999","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.36.12.1607","article-title":"Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders","volume":"36","author":"Herzog","year":"1986","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b17","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.45.9.1660","article-title":"Progesterone therapy in complex partial and secondary generalized seizures","volume":"45","author":"Herzog","year":"1995","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.1986.03380020100031","article-title":"Use of oral contraceptives by women with epilepsy","volume":"256","author":"Mattson","year":"1986","journal-title":"JAMA"},{"key":"2020102716045578000_i1551-6776-14-4-212-b19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1528-1157.1979.tb04834.x","article-title":"Do oral anticonvulsants reduce the efficacy of oral contraceptives?","volume":"20","author":"Coulam","year":"1979","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b20","unstructured":"Betts\n              T\n            , CrawfordP.\n          Women and Epilepsy. London, UK: Martin Dunitz, 1998:pp.27\u201328."},{"key":"2020102716045578000_i1551-6776-14-4-212-b21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"2020102716045578000_i1551-6776-14-4-212-b22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0010-7824(80)90102-X","article-title":"The interaction of phenobarbital and other anti-convulsants with oral contraceptive steroid therapy","volume":"22","author":"Back","year":"1980","journal-title":"Contraception"},{"key":"2020102716045578000_i1551-6776-14-4-212-b23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0009-9236(95)90172-8","article-title":"Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive","volume":"58","author":"Saano","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"2020102716045578000_i1551-6776-14-4-212-b25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and non-obese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.51.4.949","article-title":"Management issues for women with epilepsy: a review of the literature. American Academy of Neurology Practice Guidelines","volume":"51","author":"Zahn","year":"1998","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b28","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1212\/WNL.67.12_suppl_4.S56","article-title":"Optimizing therapy of seizures in women who use oral contraceptives","volume":"67","author":"Harden","year":"2006","journal-title":"Neurology"},{"issue":"suppl 7","key":"2020102716045578000_i1551-6776-14-4-212-b29","first-page":"144","article-title":"Interaction between lamotrigine and progesten\u2014only contraceptive pill containing desogestrel 75\u03bcg (Cerazette)","volume":"45","author":"Schwenkhagen","year":"2004","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1528-1157.2001.33500.x","article-title":"Valproate and the polycystic ovarian syndrome: final thoughts","volume":"42","author":"Herzog","year":"2001","journal-title":"Epilepsia"},{"issue":"suppl 7","key":"2020102716045578000_i1551-6776-14-4-212-b31","first-page":"187","article-title":"Lamotrigine plasma levels and combined monophasic oral contraceptives or a contraceptive vaginal ring, a prospective evaluation in 30 women","volume":"45","author":"Stodieck","year":"2004","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"2020102716045578000_i1551-6776-14-4-212-b33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.seizure.2007.11.013","article-title":"Which contraception in women with epilepsy?","volume":"17","author":"Schwenkhagen","year":"2008","journal-title":"Seizure"},{"key":"2020102716045578000_i1551-6776-14-4-212-b34","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.66.66_suppl_3.S23","article-title":"Menstrual disorders in women with epilepsy","volume":"66","author":"Herzog","year":"2006","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1528-1157.1980.tb04072.x","article-title":"Marriage and fertility in epileptic patients","volume":"21","author":"Dansky","year":"1980","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b36","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0140-6736(98)04512-7","article-title":"Age specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy","volume":"352","author":"Wallace","year":"1998","journal-title":"Lancet"},{"issue":"suppl 2","key":"2020102716045578000_i1551-6776-14-4-212-b37","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3949\/ccjm.71.Suppl_2.S19","article-title":"Reproductive disturbances in patients with epilepsy","volume":"71","author":"Morrell","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b38","first-page":"3078","article-title":"Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern united states: a prospective study","volume":"83","author":"Knochenhauser","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020102716045578000_i1551-6776-14-4-212-b39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1528-1157.2001.33500.x","article-title":"Valproate and the polycystic ovarian syndrome: final thoughts","volume":"42","author":"Herzog","year":"2001","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1988.tb03770.x","article-title":"Reproductive endocrine disorders in women with primary generalized epilepsy","volume":"29","author":"Bilo","year":"1988","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries - a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"2020102716045578000_i1551-6776-14-4-212-b42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2265.1992.tb02296.x","article-title":"How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?","volume":"37","author":"Clayton","year":"1992","journal-title":"Clin Endocrinol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archneur.1986.00520040029014","article-title":"Reproductive endocrine disorders in women with partial seizures of temporal lobe origin","volume":"43","author":"Herzog","year":"1986","journal-title":"Arch Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.10391","article-title":"Predictors of ovulatory failure in women with epilepsy","volume":"52","author":"Morrell","year":"2002","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b45","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jcem.86.7.7633","article-title":"Characterization of reproductive endocrine disorders in women with epilepsy","volume":"86","author":"Bilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020102716045578000_i1551-6776-14-4-212-b46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy","volume":"43","author":"Isoj\u00e4rvi","year":"1998","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b47","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isojarvi","year":"1993","journal-title":"N Engl J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF03348013","article-title":"Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy","volume":"20","author":"Murialdo","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"2020102716045578000_i1551-6776-14-4-212-b50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1059-1311(03)00065-7","article-title":"A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy","volume":"12","author":"Betts","year":"2003","journal-title":"Seizure"},{"key":"2020102716045578000_i1551-6776-14-4-212-b51","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.10391","article-title":"Predictors of ovarian failure in women with epilepsy","volume":"52","author":"Morrell","year":"2002","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b52","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000195888.51845.80","article-title":"Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry","volume":"66","author":"The EURAP study group","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 2","key":"2020102716045578000_i1551-6776-14-4-212-b53","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.3949\/ccjm.71.Suppl_2.S25","article-title":"Risks and management of pregnancy in women with epilepsy","volume":"71","author":"Yerby","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b54","first-page":"39","article-title":"The effect of pregnancy on the course of epilepsy: a prospective study","author":"Schmidt","year":"1982","journal-title":"Epilepsy, pregnancy and the child"},{"key":"2020102716045578000_i1551-6776-14-4-212-b55","first-page":"53","article-title":"Risk factors","author":"Hauser","year":"1990","journal-title":"Epilepsy: frequency, causes and consequences"},{"key":"2020102716045578000_i1551-6776-14-4-212-b56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0404.1987.tb05459.x","article-title":"Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study","volume":"75","author":"Bardy","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"2020102716045578000_i1551-6776-14-4-212-b57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0404.1988.tb03646.x","article-title":"The course of epilepsy during pregnancy: a study of 78 cases","volume":"78","author":"Gjerde","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"2020102716045578000_i1551-6776-14-4-212-b58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1528-1157.1994.tb02921.x","article-title":"Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin","volume":"35","author":"Tomson","year":"1994","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1212\/01.wnl.0000195888.51845.80","article-title":"Seizure control and treatment in pregnancy. Observations from the EURAP Epilepsy Pregnancy Registry","volume":"66","author":"The EURAP Study Group","year":"2006","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b60","first-page":"3","article-title":"The effect of pregnancy on the natural history of epilepsy: a review of the literature","author":"Schmidt","year":"1982","journal-title":"Epilepsy, Pregnancy, and the Child"},{"key":"2020102716045578000_i1551-6776-14-4-212-b61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0163-7258(87)90096-9","article-title":"Drug metabolism in pregnancy, infancy and childhood","volume":"34","author":"Perucca","year":"1987","journal-title":"Pharmacol Ther"},{"issue":"suppl 2","key":"2020102716045578000_i1551-6776-14-4-212-b62","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1212\/WNL.61.6_suppl_2.S35","article-title":"Antiepileptic drug pharmacokinetics during pregnancy and lactation","volume":"61","author":"Pennell","year":"2003","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b63","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-related changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"2020102716045578000_i1551-6776-14-4-212-b64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1528-1157.1994.tb02922.x","article-title":"Disposition of carbamezepine and phenytoin in pregnancy","volume":"34","author":"Tomson","year":"1994","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b65","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.0013-9580.2004.15104.x","article-title":"Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy","volume":"45","author":"Tomson","year":"2004","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b66","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The long term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020102716045578000_i1551-6776-14-4-212-b67","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1528-1157.1993.tb00431.x","article-title":"Guidelines for the care of women of childbearing age with epilepsy","volume":"34","author":"Commission on genetics, pregnancy and the child, international league against epilepsy","year":"1993","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b68","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"issue":"suppl 4","key":"2020102716045578000_i1551-6776-14-4-212-b69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1528-1157.44.s4.2.x","article-title":"Reproductive and Metabolic Disorders in women with epilepsy","volume":"44","author":"Morrell","year":"2003","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020102716045578000_i1551-6776-14-4-212-b71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(98)00084-9","article-title":"Congenital malformations due to anti-epileptic drugs","volume":"33","author":"Kaneko","year":"1999","journal-title":"Epilepsy Res"},{"key":"2020102716045578000_i1551-6776-14-4-212-b72","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of anti-epileptic drugs and the risk of major malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b73","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2","article-title":"Antiepileptic drug regimens and major congenital abnormalities in the off-spring","volume":"46","author":"Samren","year":"1999","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","article-title":"Major malformations in infants exposed to anti-epileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nationwide population-based register study","volume":"93","author":"Wide","year":"2004","journal-title":"Acta Paediatr"},{"key":"2020102716045578000_i1551-6776-14-4-212-b75","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM199103073241006","article-title":"Spina Bifida in infants of women treated with carbamazepine during pregnancy","volume":"324","author":"Rosa","year":"1991","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"2020102716045578000_i1551-6776-14-4-212-b76","first-page":"119","article-title":"The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"issue":"suppl 5","key":"2020102716045578000_i1551-6776-14-4-212-b77","first-page":"111","article-title":"Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs","volume":"42","author":"Lindhout","year":"1992","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b78","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000116048","article-title":"Evaluation of drug therapy and teratogenic risk in Rhone\u2013Alpes district population of pregnant women","volume":"25","author":"Robert","year":"1986","journal-title":"Eur Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b79","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b80","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","article-title":"Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian Register of Anti-epileptic Drugs in Pregnancy","volume":"11","author":"Vajda","year":"2004","journal-title":"J Clin Neurosci"},{"key":"2020102716045578000_i1551-6776-14-4-212-b81","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/01.WNL.0000163771.96962.1F","article-title":"Antiepileptic drug use of women with epilepsy and congenital malformations in offspring","volume":"64","author":"Artama","year":"2005","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b82","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Antiepileptic Drug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b83","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","article-title":"International lamotrigine pregnancy registry scientific advisory committee. Lamotrigine and the risk of malformations in pregnancy","volume":"64","author":"Cunnington","year":"2005","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b84","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.285.23.2981","article-title":"Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects","volume":"285","author":"Honein","year":"2001","journal-title":"JAMA"},{"issue":"suppl 2","key":"2020102716045578000_i1551-6776-14-4-212-b85","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.3949\/ccjm.71.Suppl_2.S49","article-title":"Recommendations for the care of women with epilepsy","volume":"71","author":"Penovich","year":"2004","journal-title":"Cleve Cl J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b86","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJM200007133430208","article-title":"Drug therapy for breast-feeding women","volume":"343","author":"Ito","year":"2000","journal-title":"N Engl J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b87","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.51.5_Suppl_4.S21","article-title":"Guidelines for the care of women with epilepsy","volume":"51","author":"Morrell","year":"1998","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b88","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2003.11.018","article-title":"Concerns regarding lamotrigine and breast-feeding","volume":"5","author":"Liporace","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"suppl 7","key":"2020102716045578000_i1551-6776-14-4-212-b89","first-page":"230","article-title":"Breast milk levels of levetiracetam after delivery","volume":"45","author":"Greenhill","year":"2004","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b90","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","article-title":"Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research database","volume":"46","author":"Souverein","year":"2005","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","article-title":"Epilepsy, osteoporosis and fracture risk: a meta analysis","volume":"112","author":"Vestergaard","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"2020102716045578000_i1551-6776-14-4-212-b92","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1528-1157.2002.15801.x","article-title":"Risk of extremity fractures in adult outpatients with epilepsy","volume":"43","author":"Persson","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"2020102716045578000_i1551-6776-14-4-212-b93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1528-1167.2006.00666.x","article-title":"Epilepsy-related injuries","volume":"47","author":"Wirrell","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"2020102716045578000_i1551-6776-14-4-212-b94","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.yebeh.2003.11.030","article-title":"Fractures, epilepsy, and antiepileptic drugs","volume":"5","author":"Mattson","year":"2004","journal-title":"Epilepsy Behav"},{"key":"2020102716045578000_i1551-6776-14-4-212-b95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.seizure.2007.11.020","article-title":"Bone health in people with epilepsy: Is it impaired and what are the risk factors?","volume":"17","author":"Pack","year":"2008","journal-title":"Seizure"},{"key":"2020102716045578000_i1551-6776-14-4-212-b96","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","article-title":"Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment","volume":"58","author":"Weinstein","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2020102716045578000_i1551-6776-14-4-212-b97","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.20378","article-title":"Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy","volume":"57","author":"Pack","year":"2005","journal-title":"Ann Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b98","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.61.6_suppl_2.S16","article-title":"Menopause and bone density issues for women with epilepsy","volume":"61","author":"Harden","year":"2003","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b99","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress","year":"2002","journal-title":"Arch Neurol"},{"key":"2020102716045578000_i1551-6776-14-4-212-b100","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/01.wnl.0000180910.72487.18","article-title":"Effect of antiepileptic drug medication on bone mineral measures","volume":"65","author":"Petty","year":"2005","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b101","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yebeh.2007.03.007","article-title":"Women with epilepsy: hormonal issues from menarche through menopause","volume":"11","author":"Cramer","year":"2007","journal-title":"Epilepsy Behav"},{"key":"2020102716045578000_i1551-6776-14-4-212-b102","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.WNL.0000081228.48016.44","article-title":"Seizure frequency is associated with age of menopause in women with epilepsy","volume":"61","author":"Harden","year":"2003","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b103","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"key":"2020102716045578000_i1551-6776-14-4-212-b104","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.wnl.0000247107.54562.0e","article-title":"Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone","volume":"67","author":"Mikati","year":"2006","journal-title":"Neurology"},{"key":"2020102716045578000_i1551-6776-14-4-212-b105","first-page":"113","article-title":"A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug induced osteomalacia","volume":"78","author":"Collins","year":"1991","journal-title":"Q J Med"},{"key":"2020102716045578000_i1551-6776-14-4-212-b106","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2362.2000.00731.x","article-title":"Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy","volume":"30","author":"Pedrera","year":"2000","journal-title":"Eur J Clin Invest"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/14\/4\/212\/1784889\/1551-6776-14_4_212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/14\/4\/212\/1784889\/1551-6776-14_4_212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:40:38Z","timestamp":1738780838000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/14\/4\/article-p212.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-14.4.212","relation":{},"ISSN":["1551-6776"],"issn-type":[{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}